Insider filing
Traded Feb 26 · filed 5 days later
Derivative exercise or conversion — not an open-market buy.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Transaction Jan 16, 2026 · Disclosed Feb 2, 2026
4 different filers disclosed AMGN within 90 days. Disclosed 17 days after the transaction; reported as an official range, not an exact amount.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
$1,001–$15,000
Official band as filed. No midpoint or exact amount is implied
Filer
17 days
Days between the transaction date and the filing date
5 disclosures on this company by this filer
4 distinct filers within 90 days
Closed at $330.41 on Jan 16, 2026, within 5% of its 52-week high, after a 4% drop over the previous 30 trading days
52-week range $262.28 (May 14, 2025) to $345.46 (Nov 28, 2025), 82% of the way up, from 251 adjusted closes. 30 trading days earlier: $345.42 on Dec 3, 2025. Describes the past only, not a forecast
RSI 52, 11% above its 200-day average, at its 50-day average, 4% below the 52-week high, 20-day volatility 24% a year, against the S&P 500: −1 points over 1 month, +7 points over 3 months, +2 points over 6 months
From the adjusted closes up to Jan 16, 2026. RSI: Wilder's 14-day relative strength index (0 to 100). Averages: the last 50 and 200 closes. Volatility: standard deviation of the last 20 daily returns, annualised. S&P 500: the stock's move minus SPY's between the same dates (21, 63 and 126 trading days). Describes the past only, not a forecast
Sponsored 3 bills in Health this Congress.
Bills (H.R. / S.) this member sponsored in the 119th Congress so far, including any introduced after the trade, grouped by the policy area the Congressional Research Service assigned (Congress.gov). Which policy areas relate to which sectors is OQRO's editorial mapping. Not a sign of what they knew or why they traded
Insider filing
Traded Feb 26 · filed 5 days later
Derivative exercise or conversion — not an open-market buy.
Esteban Santos (EVP, Operations) sold ~$11.6M of Amgen
Automatic saleInsider filing
Traded Feb 26 · filed 5 days later
Derivative exercise or conversion — not an open-market buy.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.